Cargando…
Fighting metallodrug resistance through alteration of drug metabolism and blockage of autophagic flux by mitochondria-targeting AIEgens
Metallodrug resistance has attracted a great deal of attention in cancer treatment. According to the cisplatin (cis-Pt) anticancer mechanism, a new strategy to overcome cis-Pt resistance through mitochondrial dysfunction is proposed. Two mitochondria-targeted aggregation-induced emission fluorogens...
Autores principales: | Su, Yan, Lin, Hai, Tu, Ying, Wang, Meng-Meng, Zhang, Guan-Dong, Yang, Jin, Liu, Hong-Ke, Su, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809423/ https://www.ncbi.nlm.nih.gov/pubmed/35222927 http://dx.doi.org/10.1039/d1sc06722b |
Ejemplares similares
-
Using bio-orthogonally catalyzed lethality strategy to generate mitochondria-targeting anti-tumor metallodrugs in vitro and in vivo
por: Xue, Xuling, et al.
Publicado: (2020) -
Blockage of Autophagic Flux and Induction of Mitochondria Fragmentation by Paroxetine Hydrochloride in Lung Cancer Cells Promotes Apoptosis via the ROS-MAPK Pathway
por: Wang, Kun, et al.
Publicado: (2020) -
Molecularly engineered AIEgens with enhanced quantum and singlet-oxygen yield for mitochondria-targeted imaging and photodynamic therapy
por: Xu, Fang-Zhou, et al.
Publicado: (2022) -
Cellular Basis of Organotin(IV) Derivatives as Anticancer Metallodrugs: A Review
por: Syed Annuar, Sharifah Nadhira, et al.
Publicado: (2021) -
Metallodrugs are unique: opportunities and challenges of discovery and development
por: Anthony, Elizabeth J., et al.
Publicado: (2020)